{
    "ok": true,
    "doi": "10.46243/jst.2024.v9.i2.pp72-110",
    "doi_display": "10.46243/jst.2024.v9.i2.pp72-110",
    "doi_url": "https://doi.org/10.46243/jst.2024.v9.i2.pp72-110",
    "state": "registered",
    "url": "https://jst.org.in/index.php/pub/article/view/1460",
    "title": "Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders",
    "version": 2,
    "registered_via": "crossref",
    "prefix": {
        "prefix": "10.46243",
        "status": "live"
    },
    "registrant": {
        "name": "Longman Publishers",
        "kind": "publisher",
        "country": "India"
    },
    "reserved_at": null,
    "registered_at": "2026-09-29 22:00:32",
    "updated_at": "2026-09-29 23:59:51",
    "withdrawn_at": null,
    "withdrawn_reason": null,
    "record": {
        "format": "smartscholars-doi-metadata/1.0",
        "doi": "10.46243/jst.2024.v9.i2.pp72-110",
        "referent": "Creation",
        "type": "JournalArticle",
        "structural_type": "Digital",
        "modes": [
            "Visual"
        ],
        "characters": [
            "Language"
        ],
        "titles": [
            {
                "value": "Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders",
                "type": "PrincipalTitle",
                "lang": "en"
            }
        ],
        "identifiers": [
            {
                "type": "DOI",
                "value": "10.46243/jst.2024.v9.i2.pp72-110"
            }
        ],
        "agents": [
            {
                "role": "author",
                "name": {
                    "given": "",
                    "family": "B Sandhya Rani"
                },
                "sequence": "first"
            },
            {
                "role": "author",
                "name": {
                    "given": "",
                    "family": "I. Triveni"
                },
                "sequence": "additional"
            },
            {
                "role": "author",
                "name": {
                    "given": "",
                    "family": "B.Revathi"
                },
                "sequence": "additional"
            },
            {
                "role": "author",
                "name": {
                    "given": "",
                    "family": "N. Danamurthy"
                },
                "sequence": "additional"
            },
            {
                "role": "publisher",
                "name": {
                    "org": "Longman Publishers"
                }
            }
        ],
        "dates": {
            "published": "2024-02-02",
            "date_type": "PublicationDate",
            "online": "2024-02-02"
        },
        "language": "en",
        "container": {
            "type": "Journal",
            "titles": [
                {
                    "value": "Journal of Science & Technology",
                    "type": "PrincipalTitle"
                }
            ],
            "identifiers": [
                {
                    "type": "ISSN",
                    "value": "2456-5660",
                    "medium": "electronic"
                }
            ],
            "volume": "09",
            "issue": "02",
            "pages": {
                "first": "72"
            }
        },
        "links": [
            {
                "url": "https://jst.org.in/index.php/pub/article/view/1460",
                "return_type": "text/html",
                "primary": true
            },
            {
                "url": "https://www.jst.org.in/index.php/pub/article/download/1460/1107",
                "purpose": "text-mining",
                "return_type": "application/pdf"
            },
            {
                "url": "https://www.jst.org.in/index.php/pub/article/download/1460/1379",
                "purpose": "text-mining",
                "return_type": "application/xml"
            }
        ],
        "abstract": {
            "value": "The enzymes known as sirtuins, or silent information regulator 2, are histone deacetylases that depend on nicotinamide adenine dinucleotide (NAD+). In addition to its well-established role in prolonging longevity, further study is necessary to examine the beneficial effects of Sirtuin 1 (SIRT1), a member of the sirtuin group, on lipid metabolism. SIRT1 has been extensively associated with the control of gene expression. The SIRT1 substrate sterol regulatory element-binding protein (SREBP) has garnered a lot of attention because of its involvement in a number of biological processes, such as metabolic activities, DNA damage repair, and cell cycle control. Therefore, the aim of this investigation was to examine and clarify the relationship between SIRT1 and SREBPs and evaluate the role of SIRT1/SREBPs in reducing dysfunction in lipid metabolism. Investigating whether SIRT1 and SREBPs may be used as feasible targets for therapeutic intervention in the management of diabetic complications was the aim of this study.",
            "lang": "en"
        },
        "license": {
            "url": "https://creativecommons.org/licenses/by/4.0",
            "start": "2024-02-02",
            "applies_to": "vor"
        },
        "references": [
            {
                "key": "ref1",
                "doi": "10.1038/s41580-021-00354-w",
                "unstructured": "P. Agbu, R.W. Carthew, MicroRNA-mediated regulation of glucose and lipid metabolism, Nat. Rev. Mol. Cell Biol. 22 (2021) 425–438"
            },
            {
                "key": "ref2",
                "unstructured": "Q.J. Wu, T.N. Zhang, H.H. Chen, et al., The sirtuin family in health and disease, Signal Transduct. Target Ther. 7 (2022) 402, DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3860 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders"
            },
            {
                "key": "ref3",
                "doi": "10.1073/pnas.90.24.11603",
                "unstructured": "X. Hua, C. Yokoyama, J. Wu, et al., SREBP-2, a second basic-helix-loop-helix- leucine zipper protein that stimulates transcription by binding to a sterol regulatory element, Proc. Natl. Acad. Sci. USA 90 (1993) 11603–11607"
            },
            {
                "key": "ref4",
                "doi": "10.1016/0092-8674(94)90234-8",
                "unstructured": "X. Wang, R. Sato, M.S. Brown, et al., SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis, Cell 77 (1994) 53–62"
            },
            {
                "key": "ref5",
                "doi": "10.1074/jbc.270.49.29422",
                "unstructured": "X. Hua, J. Sakai, Y.K. Ho, et al., Hairpin orientation of sterol regulatory element- binding protein-2 in cell membranes as determined by protease protection, J. Biol. Chem. 270 (1995) 29422–29427W. Dang, The controversial world of sirtuins, Drug Discov. Today Technol. 12 (2014) e9–e17, J. Rine, J.N. Strathern, J.B. Hicks, et al., A suppressor of mating-type locus mutations in Saccharomyces cerevisiae: evidence for and identification of cryptic mating-type loci, Genetics 93 (1979) 877–901"
            },
            {
                "key": "ref6",
                "doi": "10.1186/1479-7364-5-5-485",
                "unstructured": "A. Vassilopoulos, K.S. Fritz, D.R. Petersen, et al., The human sirtuin family: evolutionary divergences and functions, Hum. Genom. 5 (2011) 485–496"
            },
            {
                "key": "ref7",
                "doi": "10.1016/j.tig.2014.04.007",
                "unstructured": "W. Giblin, M.E. Skinner, D.B. Lombard, Sirtuins: guardians of mammalian healthspan, Trends Genet 30 (2014) 271–286J. Min, J. Landry, R. Fau-Sternglanz, R. Sternglanz, R.M. Fau-Xu, et al., Cryst. Struct. a SIR2 Homol. -NAD Complex (2001) 269–279"
            },
            {
                "key": "ref8",
                "doi": "10.1186/gb-2004-5-5-224",
                "unstructured": "B.J. North, E. Verdin, Sirtuins: Sir2-Relat. NAD-Depend. Protein deacetylases (2004) 224"
            },
            {
                "key": "ref9",
                "doi": "10.1101/cshperspect.a018713",
                "unstructured": "E. Seto, M. Yoshida, Erasers of histone acetylation: the histone deacetylase enzymes, Cold Spring Harb. Perspect. Biol. 6 (2014) a018713"
            },
            {
                "key": "ref10",
                "doi": "10.3390/ijms23179790",
                "unstructured": "P. Vong, H. Ouled-Haddou, L. Garçon, Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis, Int J. Mol. Sci. 23 (2022)"
            },
            {
                "key": "ref11",
                "doi": "10.2174/1570159x19666210609160017",
                "unstructured": "V. Kumar, S. Kundu, A. Singh, et al., Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective, Curr. Neuropharmacol. 20 (2022) 158–178"
            },
            {
                "key": "ref12",
                "doi": "10.1038/35001622",
                "unstructured": "S. Imai, C.M. Armstrong, M. Kaeberlein, et al., Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase, Nature 403 (2000) 795–800"
            },
            {
                "key": "ref13",
                "doi": "10.1038/nrm3293",
                "unstructured": "R.H. Houtkooper, E. Pirinen, J. Auwerx, Sirtuins as regulators of metabolism and healthspan, Nat. Rev. Mol. Cell Biol. 13 (2012) 225–238"
            },
            {
                "key": "ref14",
                "doi": "10.1006/bbrc.2000.3000",
                "unstructured": "R.A. Frye, Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins, Biochem Biophys. Res Commun. 273 (2000) 793–798"
            },
            {
                "key": "ref15",
                "doi": "10.1074/jbc.r112.372300",
                "unstructured": "H. Yuan, R. Marmorstein, Structural basis for sirtuin activity and inhibition, J. Biol. Chem. 287 (2012) 42428–42435V. Carafa, D. Rotili, M. Forgione, et al., Sirtuin functions and modulation: from chemistry to the clinic, Clin. Epigenetics 8 (2016), 61"
            },
            {
                "key": "ref16",
                "doi": "10.1038/s41467-018-06812-y",
                "unstructured": "Z. Wei, J. Song, G. Wang, et al., Deacetylation of serine hydroxymethyl- transferase 2 by SIRT3 promotes colorectal carcinogenesis, Nat. Commun. 9 (2018), 4468"
            },
            {
                "key": "ref17",
                "doi": "10.1186/1476-4598-12-68",
                "unstructured": "I.C. Chen, W.F. Chiang, S.Y. Liu, et al., Role of SIRT3 in the regulation of redox balance during oral carcinogenesis, Mol. Cancer 12 (2013), 68"
            },
            {
                "key": "ref18",
                "doi": "10.1186/1476-4598-13-187",
                "unstructured": "W. Yao, S. Ji, Y. Qin, et al., Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axis, Mol. Cancer 13 (2014), 187"
            },
            {
                "key": "ref19",
                "doi": "10.1016/j.jsbmb.2018.07.005",
                "unstructured": "D. Xu, H. He, X. Jiang, et al., SIRT2 plays a novel role on progesterone, estradiol and testosterone synthesis via PPARs/LXRα pathways in bovine ovarian granular cells, J. Steroid Biochem Mol. Biol. 185 (2019) 27–38"
            },
            {
                "key": "ref20",
                "doi": "10.1016/j.celrep.2019.01.057",
                "unstructured": "K.H. Fisher-Wellman, J.A. Draper, M.T. Davidson, et al., Respiratory Phenomics across Multiple Models of Protein Hyperacylation in Cardiac Mitochondria Reveals a Marginal Impact on Bioenergetics, e1558, Cell Rep. 26 (2019) 1557–1572"
            },
            {
                "key": "ref21",
                "doi": "10.3389/fimmu.2019.02341",
                "unstructured": "T. Heinonen, E. Ciarlo, D. Le Roy, et al., Impact of the Dual Deletion of the Mitochondrial Sirtuins SIRT3 and SIRT5 on Anti-microbial Host Defenses, Front Immunol. 10 (2019), 2341"
            },
            {
                "key": "ref22",
                "doi": "10.1111/febs.15110",
                "unstructured": "G. Nowak, J. Megyesi, Protein kinase Cα mediates recovery of renal and mitochondrial functions following acute injury, Febs J. 287 (2020) 1830–1849, M.C. Haigis, R. Mostoslavsky, K.M. Haigis, et al., SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells, Cell 126 (2006) 941–954"
            },
            {
                "key": "ref23",
                "doi": "10.1016/j.gene.2021.146135",
                "unstructured": "A. Akkulak, G.D. Yalcin, The interaction of SIRT4 and Calreticulin during ER stress in glia cells, Gene 814 (2022), 146135"
            },
            {
                "key": "ref24",
                "doi": "10.1038/s41598-022-16610-8",
                "unstructured": "G. Cai, Z. Ge, Y. Xu, et al., SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism, Sci. Rep. 12 (2022), 12208"
            },
            {
                "key": "ref25",
                "unstructured": "W. Wei, P. Hu, M. Qin, et al., SIRT4 Is Highly DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3861 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders Expressed in Retinal Müller Glial Cells, Front Neurosci. 16 (2022), 840443"
            },
            {
                "key": "ref26",
                "doi": "10.3389/fnins.2022.1035444",
                "unstructured": "H. Weng, W. Song, K. Fu, et al., Proteomic profiling reveals the potential mechanisms and regulatory targets of sirtuin 4 in 1-methyl-4-phenyl- 1,2,3,6-tet- rahydropyridine-induced Parkinson’s mouse model, Front Neurosci. 16 (2022), 1035444"
            },
            {
                "key": "ref27",
                "doi": "10.1038/s41418-022-01063-3",
                "unstructured": "J. Li, H. Zhan, Y. Ren, et al., Sirtuin 4 activates autophagy and inhibits tumorigenesis by upregulating the p53 signaling pathway, Cell Death Differ. 30 (2023) 313–326"
            },
            {
                "key": "ref28",
                "doi": "10.7717/peerj.14752",
                "unstructured": "X. Quan, Y. Xin, H.L. Wang, et al., Implications of altered sirtuins in metabolic regulation and oral cancer, PeerJ 11 (2023), e14752"
            },
            {
                "key": "ref29",
                "doi": "10.1016/j.cmet.2013.11.013",
                "unstructured": "M.J. Rardin, W. He, Y. Nishida, et al., SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks, Cell Metab. 18 (2013) 920–933"
            },
            {
                "key": "ref30",
                "doi": "10.1016/j.cell.2008.10.052",
                "unstructured": "T.L. Kawahara, E. Michishita, A.S. Adler, et al., SIRT6 links histone H3 lysine 9 deacetylation to NFkappaB-dependent gene expression and organismal life span, Cell 136 (2009) 62–74"
            },
            {
                "key": "ref31",
                "doi": "10.1152/physrev.00030.2018",
                "unstructured": "A.R. Chang, C.M. Ferrer, R. Mostoslavsky, SIRT6, a Mammalian Deacylase with Multitasking Abilities, Physiol. Rev. 100 (2020) 145–169"
            },
            {
                "key": "ref32",
                "doi": "10.1016/j.kint.2017.10.021",
                "unstructured": "Z. Li, K. Xu, N. Zhang, et al., Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling, Kidney Int 93 (2018) 881–892"
            },
            {
                "key": "ref33",
                "doi": "10.1021/acschembio.2c00348",
                "unstructured": "V.I. Kuznetsov, W.H. Liu, M.A. Klein, et al., Potent Activation of NAD( +)- Dependent Deacetylase Sirt7 by Nucleosome Binding, ACS Chem. Biol. 17 (2022) 2248–2261"
            },
            {
                "key": "ref34",
                "doi": "10.1080/10408398.2022.2070722",
                "unstructured": "S. Pande, S. Raisuddin, Molecular and cellular regulatory roles of sirtuin protein, Crit. Rev. Food Sci. Nutr. (2022) 1–19"
            },
            {
                "key": "ref35",
                "doi": "10.1038/ncomms12235",
                "unstructured": "L. Li, L. Shi, S. Yang, et al., SIRT7 is a histone desuccinylase that functionally links to chromatin compaction and genome stability, Nat. Commun. 7 (2016), 12235"
            },
            {
                "key": "ref36",
                "doi": "10.1016/j.molcel.2019.08.018",
                "unstructured": "X. Bao, Z. Liu, W. Zhang, et al., Glutarylation of histone h4 lysine 91 regulates chromatin dynamics, e669, Mol. Cell 76 (2019) 660–675"
            },
            {
                "key": "ref37",
                "doi": "10.1177/1087057111422103",
                "unstructured": "W. Stünkel, R.M. Campbell, Sirtuin 1 (SIRT1): the misunderstood HDAC, J. Biomol. Screen 16 (2011) 1153–1169"
            },
            {
                "key": "ref38",
                "doi": "10.3389/fphar.2020.00355",
                "unstructured": "Y. Yao, W. Zhang, R. Ming, et al., Noninvasive 40-Hz light flicker rescues circadian behavior and abnormal lipid metabolism induced by acute ethanol exposure via improving SIRT1 and the circadian clock in the liver-brain axis, Front Pharm. 11 (2020), 355"
            },
            {
                "key": "ref39",
                "doi": "10.1161/jaha.113.000042",
                "unstructured": "S. Venkatasubramanian, R.M. Noh, S. Daga, et al., Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokers, J. Am. Heart Assoc. 2 (2013), e000042"
            },
            {
                "key": "ref40",
                "doi": "10.1016/j.trsl.2023.02.004",
                "unstructured": "M. Kurano, K. Tsukamoto, T. Shimizu, et al., Apolipoprotein M/sphingosine 1- phosphate protects against diabetic nephropathy, Transl. Res (2023) 16–34"
            },
            {
                "key": "ref41",
                "doi": "10.1016/j.cmet.2020.10.019",
                "unstructured": "Y. Fu, Y. Sun, M. Wang, et al., Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism, e1058, Cell Metab. 32 (2020) 1052–1062"
            },
            {
                "key": "ref42",
                "doi": "10.3389/fphys.2017.00446",
                "unstructured": "L. Zhang, R. Tu, Y. Wang, et al., Early-Life exposure to lead induces cognitive impairment in elder mice targeting SIRT1 phosphorylation and oxidative alterations, Front Physiol. 8 (2017), 446"
            },
            {
                "key": "ref43",
                "doi": "10.3389/fphys.2022.782684",
                "unstructured": "M. Eid, V. Dzreyan, S. Demyanenko, Sirtuins 1 and 2 in the acute period after photothrombotic stroke: expression, localization and involvement in apoptosis, Front Physiol. 13 (2022), 782684"
            },
            {
                "key": "ref44",
                "doi": "10.1016/j.redox.2023.102615",
                "unstructured": "T. Jiang, T. Qin, P. Gao, et al., SIRT1 attenuates blood-spinal cord barrier disruption after spinal cord injury by deacetylating p66Shc, Redox Biol. 60 (2023), 102615"
            },
            {
                "key": "ref45",
                "doi": "10.1111/acel.13812",
                "unstructured": "Y. Yu, X. Song, X. Wang, et al., Oxidative stress impairs the Nur77-Sirt1 axis resulting in a decline in organism homeostasis during aging, Aging Cell (2023), e13812"
            },
            {
                "key": "ref46",
                "doi": "10.1039/c8ra09914f",
                "unstructured": "X. Song, F. Kong, Z. Zong, et al., miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1, RSC Adv. 9 (2019) 5234–524"
            },
            {
                "key": "ref47",
                "doi": "10.1097/tp.0000000000003435",
                "unstructured": "S.H. Dai, L.J. Chen, W.H. Qi, et al., microRNA-145 Inhibition Upregulates SIRT1 and Attenuates Autophagy in a Mouse Model of Lung Ischemia/ Reperfusion Injury via NF-κB-dependent Beclin 1, Transplantation 105 (2021) 529–539"
            },
            {
                "key": "ref48",
                "doi": "10.3389/fphys.2021.624989",
                "unstructured": "W. Dong, H. Zhang, C. Zhao, et al., Silencing of miR-150-5p ameliorates diabetic nephropathy by targeting SIRT1/p53/AMPK Pathway, Front Physiol. 12 (2021), 624989"
            },
            {
                "key": "ref49",
                "doi": "10.3892/or.2020.7825",
                "unstructured": "H.G. Zhang, F.J. Wang, Y. Wang, et al., lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3862 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders regulatory loop with the miR-34a/mTOR/SIRT1 pathway in colorectal cancer, Oncol. Rep. 45 (2021) 202–216"
            },
            {
                "key": "ref50",
                "doi": "10.1080/15548627.2022.2062112",
                "unstructured": "Y. Xu, W. Wan, Acetylation in the regulation of autophagy, Autophagy 19 (2023) 379–387"
            },
            {
                "key": "ref51",
                "doi": "10.3389/fphar.2023.1111320",
                "unstructured": "Y. Wang, R. Zhao, C. Wu, et al., Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling, Front Pharm. 14 (2023), 1111320"
            },
            {
                "key": "ref52",
                "doi": "10.1016/j.biopha.2023.114417",
                "unstructured": "H.H. Chen, Y.X. Zhang, J.L. Lv, et al., Role of sirtuins in metabolic disease-related renal injury, Biomed. Pharm. 161 (2023), 114417"
            },
            {
                "key": "ref53",
                "doi": "10.3390/nu15071626",
                "unstructured": "H. Kang, S. Kim, J.Y. Lee, et al., Inhibitory effects of ginsenoside compound K on lipopolysaccharidestimulated inflammatory responses in macrophages by regulating sirtuin 1 and histone deacetylase 4, Nutrients 15 (2023) 1626"
            },
            {
                "key": "ref54",
                "doi": "10.1016/j.biopha.2023.114573",
                "unstructured": "C. Sun, S. Bai, Y. Liang, et al., The role of Sirtuin 1 and its activators in age-related lung disease, Biomed. Pharm. 162 (2023), 114573"
            },
            {
                "key": "ref55",
                "doi": "10.3390/cells9041053",
                "unstructured": "Miranda-Gonçalves, V. Lameirinhas, A. Macedo-Silva C, et al., Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation, Cells 9 (2020) 1053"
            },
            {
                "key": "ref56",
                "doi": "10.1002/jcb.27653",
                "unstructured": "X.J. Yu, X.Z. Guo, C. Li, et al., SIRT1-ZEB1positive feedback promotes epithelial- mesenchymal transition process and metastasis of osteosarcoma, J. Cell Biochem 120 (2019) 3727–3735"
            },
            {
                "key": "ref57",
                "doi": "10.1016/j.devcel.2019.03.011",
                "unstructured": "A. Latifkar, L. Ling, A. Hingorani, et al., Loss of sirtuin 1 alters the secretome of breast cancer cells by impairing lysosomal integrity, e397, Dev. Cell 49 (2019) 393–408"
            },
            {
                "key": "ref58",
                "doi": "10.1038/s41419-018-0582-1",
                "unstructured": "Y. Liang, X. Song, Y. Li, et al., A novel long noncoding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer, Cell Death Dis. 9 (2018), 563"
            },
            {
                "key": "ref59",
                "doi": "10.18632/oncotarget.25771",
                "unstructured": "K. Rifaï, G. Judes, M. Idrissou, et al., SIRT1dependent epigenetic regulation of H3 and H4 histone acetylation in human breast cancer, Oncotarget 9 (2018) 30661–30678"
            },
            {
                "key": "ref60",
                "doi": "10.1093/cvr/cvac026",
                "unstructured": "A. Kuno, R. Hosoda, M. Tsukamoto, et al., SIRT1 in the cardiomyocyte counteracts doxorubicininduced cardiotoxicity via regulating histone H2AX, Cardiovasc Res 118 (2023) 3360–3373"
            },
            {
                "key": "ref61",
                "doi": "10.3390/nu12092726",
                "unstructured": "M.S. Lee, Y. Kim, Chrysanthemum morifolium Flower Extract Inhibits Adipogenesis of 3T3-L1 Cells via AMPK/SIRT1 Pathway Activation, Nutrients 12 (2020) 2726"
            },
            {
                "key": "ref62",
                "doi": "10.3390/cells11071076",
                "unstructured": "M. Park, H. Baek, J.Y. Han, et al., Stevioside Enhances the Anti-Adipogenic Effect and β-Oxidation by Activating AMPK in 3T3-L1 Cells and Epididymal Adipose Tissues of db/db Mice, Cells 11 (2022) 1076"
            },
            {
                "key": "ref63",
                "doi": "10.1016/j.foodres.2022.111396",
                "unstructured": "Z. Chai, Y. Yan, S. Zan, et al., Probioticfermented blueberry pomace alleviates obesity and hyperlipidemia in high-fat diet C57BL/6J mice, Food Res Int 157 (2022), 111396"
            },
            {
                "key": "ref64",
                "doi": "10.3390/foods11111606",
                "unstructured": "J. Bai, T. Yang, Y. Zhou, et al., Octacosanol modifies obesity, expression profile and inflammation response of hepatic tissues in high-fat diet mice, Foods 11 (2022) 1606"
            },
            {
                "key": "ref65",
                "doi": "10.1016/j.tibs.2018.01.005",
                "unstructured": "R.A. DeBose-Boyd, J. Ye, SREBPs in lipid metabolism, insulin signaling, and beyond, Trends Biochem Sci. 43 (2018) 358–368"
            },
            {
                "key": "ref66",
                "doi": "10.1016/s0092-8674(00)81362-8",
                "unstructured": "X. Hua, A. Nohturfft, J.L. Goldstein, et al., Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein, Cell 87 (1996) 415–426"
            },
            {
                "key": "ref67",
                "doi": "10.1074/jbc.272.32.20213",
                "unstructured": "J. Sakai, A. Nohturfft, D. Cheng, et al., Identification of complexes between the COOHterminal domains of sterol regulatory elementbinding proteins (SREBPs) and SREBP cleavageactivating protein, J. Biol. Chem. 272 (1997) 20213–20221"
            },
            {
                "key": "ref68",
                "doi": "10.1074/jbc.273.27.17243",
                "unstructured": "A. Nohturfft, M.S. Brown, J.L. Goldstein, Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain, J. Biol. Chem. 273 (1998) 17243–17250"
            },
            {
                "key": "ref69",
                "doi": "10.1016/0888-7543(95)80009-b",
                "unstructured": "X. Hua, J. Wu, J.L. Goldstein, et al., Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13, Genomics 25 (1995) 667–673"
            },
            {
                "key": "ref70",
                "doi": "10.1172/jci119247",
                "unstructured": "I. Shimomura, H. Shimano, J.D. Horton, et al., Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells, J. Clin. Invest 99 (1997) 838–845"
            },
            {
                "key": "ref71",
                "doi": "10.1016/j.biochi.2004.09.018",
                "unstructured": "D. Eberl´e, B. Hegarty, P. Bossard, et al., SREBP transcription factors: master regulators of lipid homeostasis, Biochimie 86 (2004) 839–848, M.S. Brown, J.L. Goldstein, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell 89 (1997) 331–340, DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3863 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders"
            },
            {
                "key": "ref72",
                "doi": "10.1172/jci119248",
                "unstructured": "H. Shimano, J.D. Horton, I. Shimomura, et al., Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells, J. Clin. Invest 99 (1997) 846–854"
            },
            {
                "key": "ref73",
                "doi": "10.1016/j.atherosclerosis.2010.08.046",
                "unstructured": "J. Kotzka, B. Knebel, H. Avci, et al., Phosphorylation of sterol regulatory element- binding protein (SREBP)-1a links growth hormone action to lipid metabolism in hepatocytes, Atherosclerosis 213 (2010) 156–165"
            },
            {
                "key": "ref74",
                "doi": "10.1016/j.neuro.2017.02.001",
                "unstructured": "Y. An, D.D. Zhang, H.L. Yu, et al., 27-Hydroxycholesterol regulates cholesterol synthesis and transport in C6 glioma cells, Neurotoxicology 59 (2017) 88–97"
            },
            {
                "key": "ref75",
                "doi": "10.1172/jci0215593",
                "unstructured": "J.D. Horton, J.L. Goldstein, M.S. Brown, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest 109 (2002) 1125–1131"
            },
            {
                "key": "ref76",
                "doi": "10.1038/s41467-022-34931-0",
                "unstructured": "M. Ruiz, R. Devkota, D. Panagaki, et al., Sphingosine 1-phosphate mediates adiponectin receptor signaling essential for lipid homeostasis and embryogenesis, Nat. Commun. 13 (2022), 7162"
            },
            {
                "key": "ref77",
                "doi": "10.1002/advs.202205451",
                "unstructured": "W.J. Chen, W.K. Huang, S.R. Pather, et al., Podocalyxin-Like protein 1 regulates pluripotency through the cholesterol biosynthesis pathway, Adv. Sci. (Weinh.) 10 (2022), e2205451"
            },
            {
                "key": "ref78",
                "doi": "10.1172/jci164118",
                "unstructured": "V. Sengottuvel, M. Hota, J. Oh, et al., Deficiency in the omega-3 lysolipid transporter Mfsd2a leads to aberrant oligodendrocyte lineage development and hypomyelination, J. Clin. Invest (2023)"
            },
            {
                "key": "ref79",
                "doi": "10.1038/s41467-023-36298-2",
                "unstructured": "R. Ganji, J.A. Paulo, Y. Xi, et al., The p97-UBXD8 complex regulates ER-Mitochondria contact sites by altering membrane lipid saturation and composition, Nat. Commun. 14 (2023), 638"
            },
            {
                "key": "ref80",
                "doi": "10.1016/j.cmet.2022.08.005",
                "unstructured": "J.Y. Kim, L.Q. Wang, V.C. Sladky, et al., PIDDosome-SCAP crosstalk controls high- fructosediet-dependent transition from simple steatosis to steatohepatitis, e1546, Cell Metab. 34 (2022) 1548–1560"
            },
            {
                "key": "ref81",
                "doi": "10.1097/hep.0000000000000433",
                "unstructured": "G. Li, H. Chen, F. Shen, et al., Targeting hepatic serine-arginine protein kinase 2 ameliorates alcoholassociated liver disease by alternative splicing control of lipogenesis, Hepatology (2023) 1506–1524"
            },
            {
                "key": "ref82",
                "doi": "10.1002/advs.202370079",
                "unstructured": "X. Fang, J. Zhang, Y. Li, et al., Malic Enzyme 1 as a Novel Anti-Ferroptotic Regulator in Hepatic Ischemia/Reperfusion Injury, Adv. Sci. (Weinh.) 10 (2023), e2205436, J.Q. Wang, L.L. Li, A. Hu, et al., Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion, Nature 608 (2022) 413–420"
            },
            {
                "key": "ref83",
                "doi": "10.1002/cac2.12247",
                "unstructured": "D. Wu, Y. Yang, Y. Hou, et al., Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1, Cancer Commun. (Lond.) 42 (2022) 37–55"
            },
            {
                "key": "ref84",
                "doi": "10.1016/j.jhep.2022.02.018",
                "unstructured": "A. Husain, Y.T. Chiu, K.M. Sze, et al., Ephrin-A3/ EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma, J. Hepatol. 77 (2022) 383–396"
            },
            {
                "key": "ref85",
                "doi": "10.1016/j.cmet.2022.06.009",
                "unstructured": "H.M. Lee, A. Nayak, J. Kim, A new role for ammonia in tumorigenesis, Cell Metab. 34 (2022) 944–946"
            },
            {
                "key": "ref86",
                "doi": "10.1038/s42255-022-00568-y",
                "unstructured": "C. Cheng, F. Geng, Z. Li, et al., Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth, Nat. Metab. 4 (2022) 575–588"
            },
            {
                "key": "ref87",
                "doi": "10.1038/s41467-023-37501-0",
                "unstructured": "I. Mahmud, G. Tian, J. Wang, et al., DAXX drives de novo lipogenesis and contributes to tumorigenesis, Nat. Commun. 14 (2023), 1927"
            },
            {
                "key": "ref88",
                "doi": "10.1002/cac2.12341",
                "unstructured": "W. Dai, W. Xiang, L. Han, et al., PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism, Cancer Commun. (Lond.) 42 (2022) 848–867"
            },
            {
                "key": "ref89",
                "doi": "10.3389/fonc.2020.01510",
                "unstructured": "L. Xue, H. Qi, H. Zhang, et al., Targeting SREBP- 2-Regulated Mevalonate Metabolism for Cancer Therapy, Front Oncol. 10 (2020), 1510"
            },
            {
                "key": "ref90",
                "doi": "10.1074/jbc.m800910200",
                "unstructured": "M. Arito, T. Horiba, S. Hachimura, et al., Growth factor-induced phosphorylation of sterol regulatory element-binding proteins inhibits sumoylation, thereby stimulating the expression of their target genes, low density lipoprotein uptake, and lipid synthesis, J. Biol. Chem. 283 (2008) 15224–15231"
            },
            {
                "key": "ref91",
                "doi": "10.1038/s41467-022-28240-9",
                "unstructured": "P.F. Lebeau, J.H. Byun, K. Platko, et al., Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance, Nat. Commun. 13 (2022), 770"
            },
            {
                "key": "ref92",
                "doi": "10.1002/advs.202102669",
                "unstructured": "Z. Lu, L. Huang, Y. Li, et al., Fine-tuning of cholesterol homeostasis controls erythroid differentiation, Adv. Sci. (Weinh.) 9 (2022), e2102669"
            },
            {
                "key": "ref93",
                "doi": "10.1161/atvbaha.122.317898",
                "unstructured": "J. Chen, H. Zhang, L. Li, et al., Lp-PLA(2) (Lipoprotein-associated phospholipase a (2)) deficiency lowers cholesterol levels and protects against atherosclerosis in rabbits, Arterioscler. Thromb. Vasc. Biol. 43 (2023) e11–e28, A.M. Doerfler, J. Han, K.E. Jarrett, et al., Intestinal Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell Compartment, Arterioscler. Thromb. Vasc. Biol. 42 (2022) 381–394, DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3864 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders"
            },
            {
                "key": "ref94",
                "doi": "10.1161/atvbaha.122.318138",
                "unstructured": "H. Liu, M. Hallauer Hastings, R. Kitchen, et al., Beneficial effects of moderate hepatic activin a expression on metabolic pathways, inflammation, and atherosclerosis, Arterioscler. Thromb. Vasc. Biol. 43 (2023) 330–349"
            },
            {
                "key": "ref95",
                "doi": "10.1038/s41418-022-01071-3",
                "unstructured": "H.M. Cheng, M. Xing, Y.P. Zhou, et al., HSP90β promotes osteoclastogenesis by dual-activation of cholesterol synthesis and NF-κB signaling, Cell Death Differ. 30 (2023) 673–686"
            },
            {
                "key": "ref96",
                "doi": "10.1038/s41423-022-00872-3",
                "unstructured": "W. Tang, J. Zhou, W. Yang, et al., Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver, Cell Mol. Immunol. 19 (2022) 834–847"
            },
            {
                "key": "ref97",
                "doi": "10.1016/j.phrs.2022.106324",
                "unstructured": "H. Zou, Y. Yang, Z. Shi, et al., Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy, Pharm. Res 182 (2022), 106324"
            },
            {
                "key": "ref98",
                "doi": "10.1038/s41467-022-33041-1",
                "unstructured": "E. Branche, Y.T. Wang, K.M. Viramontes, et al., SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus, Nat. Commun. 13 (2022), 5341"
            },
            {
                "key": "ref99",
                "doi": "10.1172/jci118951",
                "unstructured": "H. Shimano, J.D. Horton, R.E. Hammer, et al., Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a, J. Clin. Invest 98 (1996) 1575–1584"
            },
            {
                "key": "ref100",
                "doi": "10.1073/pnas.2203894119",
                "unstructured": "W. Chen, L. Wen, Y. Bao, et al., Gut flora disequilibrium promotes the initiation of liver cancer by modulating tryptophan metabolism and upregulating SREBP2, Proc. Natl. Acad. Sci. USA 119 (2022), e2203894119"
            },
            {
                "key": "ref101",
                "doi": "10.3389/fphar.2021.689767",
                "unstructured": "C. Zheng, Y. Zhu, Q. Liu, et al., Maprotiline suppresses cholesterol biosynthesis and hepatocellular carcinoma progression through direct targeting of CRABP1, Front Pharm. 12 (2021), 689767"
            },
            {
                "key": "ref102",
                "doi": "10.1038/s41467-022-28452-z",
                "unstructured": "Y.Y. Chen, J.Y. Ge, S.Y. Zhu, et al., Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis, Nat. Commun. 13 (2022), 791"
            },
            {
                "key": "ref103",
                "doi": "10.1158/0008-5472.can-21-3822",
                "unstructured": "X. Shangguan, Z. Ma, M. Yu, et al., Squalene epoxidase metabolic dependency is a targetable vulnerability in castration-resistant prostate cancer, Cancer Res 82 (2022) 3032–3044"
            },
            {
                "key": "ref104",
                "doi": "10.1093/neuonc/noad060",
                "unstructured": "D. Gu, F. Zhou, H. You, et al., SREBP2 maintains glioblastoma stem cells through keeping the balance between cholesterol biosynthesis and uptake, Neuro Oncol. (2023) 1578–1591"
            },
            {
                "key": "ref105",
                "doi": "10.1038/s41418-023-01173-6",
                "unstructured": "C.R. Maier, O. Hartmann, C. Prieto-Garcia, et al., USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer, Cell Death Differ. (2023) 1710–1725"
            },
            {
                "key": "ref106",
                "doi": "10.3390/biom11020241",
                "unstructured": "U.N. Das, Cell Membrane Theory of Senescence” and the Role of Bioactive Lipids in Aging, and Aging Associated Diseases and Their Therapeutic Implications, Biomolecules 11 (2021) 241"
            },
            {
                "key": "ref107",
                "doi": "10.1080/10408398.2018.1544542",
                "unstructured": "M. Wang, L.J. Ma, Y. Yang, et al., n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review, Crit. Rev. Food Sci. Nutr. 59 (2019) S116–s129"
            },
            {
                "key": "ref108",
                "doi": "10.3390/ijms222313163",
                "unstructured": "M.H. Yu, T.W. Hung, C.C. Wang, et al., Neochlorogenic acid attenuates hepatic lipid accumulation and inflammation via regulating mir- 34a in vitro, Int J. Mol. Sci. 22 (2021) 13163"
            },
            {
                "key": "ref109",
                "doi": "10.1186/s12906-022-03697-9",
                "unstructured": "Y. Liu, Y. Li, J. Wang, et al., Salvia-Nelumbinis naturalis improves lipid metabolism of NAFLD by regulating the SIRT1/AMPK signaling pathway, BMC Complement Med Ther. 22 (2022), 213"
            },
            {
                "key": "ref110",
                "doi": "10.1111/bph.15007",
                "unstructured": "Y. Zhang, M. Jiang, B.W. Cui, et al., P2×7 receptor-targeted regulation by tetrahydroxystilbene glucoside in alcoholic hepatosteatosis: A new strategy towards macrophage-hepatocyte crosstalk, Br. J. Pharm. 177 (2020) 2793–2811"
            },
            {
                "key": "ref111",
                "doi": "10.1021/acs.jafc.2c00641",
                "unstructured": "H.Y. Tsai, Y.Y. Shih, Y.T. Yeh, et al., Pterostilbene and Its Derivative 3′-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway, J. Agric. Food Chem. 70 (2022) 4966–4980"
            },
            {
                "key": "ref112",
                "doi": "10.3389/fnut.2023.1101341",
                "unstructured": "E. Paolini, M. Longo, M. Meroni, et al., The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value, Front Nutr. 10 (2023), 1101341"
            },
            {
                "key": "ref113",
                "doi": "10.1186/s41021-022-00246-1",
                "unstructured": "X. Xu, X. Deng, Y. Chen, et al., SIRT1 mediates nutritional regulation of SREBP-1c- driven hepatic PNPLA3 transcription via modulation of H3k9 acetylation, Genes Environ. 44 (2022) 18"
            },
            {
                "key": "ref114",
                "doi": "10.1016/j.joim.2021.09.003",
                "unstructured": "M.Y. Shan, Y. Dai, X.D. Ren, et al., Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis, J. Integr. Med 19 (2021) 545–554,. DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3865 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders"
            },
            {
                "key": "ref115",
                "doi": "10.2139/ssrn.4261541",
                "unstructured": "C. Liang, H. Xing, C. Wang, et al., Resveratrol improves the progression of osteoarthritis by regulating the sirt1-foxo1 pathway-mediated cholesterol metabolism, Mediat. Inflamm. 2023 (2023), 2936236"
            },
            {
                "key": "ref116",
                "doi": "10.1007/s11596-016-1645-0",
                "unstructured": "F. Yu, H. Zeng, M. Lei, et al., Effects of SIRT1 gene knock-out via activation of SREBP2 proteinmediated PI3K/AKT signaling on osteoarthritis in mice, J. Huazhong Univ. Sci. Technol. Med Sci. 36 (2016) 683–690H. Xing, C. Liang, C. Wang, et al., Metformin mitigates cholesterol accumulation via the AMPK/SIRT1 pathway to protect osteoarthritis chondrocytes, Biochem Biophys. Res Commun. 632 (2022) 113–121"
            },
            {
                "key": "ref117",
                "doi": "10.3390/antiox11122363",
                "unstructured": "D.P. Leal, G.H.F. Gonçalinho, T.M. Tavoni, et al., The Interplay of Sirtuin-1, LDL-Cholesterol, and HDL Function: A Randomized Controlled Trial Comparing the Effects of Energy Restriction and Atorvastatin on Women with Premature Coronary Artery Disease, Antioxid. (Basel) 11 (2022) 2363"
            },
            {
                "key": "ref118",
                "doi": "10.1155/2020/3413186",
                "unstructured": "J. Zhang, H. Du, M. Shen, et al., Kangtaizhi granule alleviated nonalcoholic fatty liver disease in high-fat diet-fed rats and HepG2 Cells via AMPK/ mTOR signaling pathway, J. Immunol. Res 2020 (2020) 3413186"
            },
            {
                "key": "ref119",
                "doi": "10.1016/j.lfs.2021.120219",
                "unstructured": "L. Wang, H.S. Choi, Y. Su, et al., The docosahexaenoic acid derivatives, diHEP-DPA and TH-DPA, synthesized via recombinant lipoxygenase, ameliorate disturbances in lipid metabolism and liver inflammation in high fat diet-fed mice, Life Sci. 291 (2022), 120219"
            },
            {
                "key": "ref120",
                "doi": "10.1007/s40199-023-00458-y",
                "unstructured": "H. Shamardl, N.A. Ibrahim, D.H. Merzeban, et al., Resveratrol and Dulaglutide ameliorate adiposity and liver dysfunction in rats with diet-induced metabolic syndrome: Role of SIRT-1 / adipokines / PPARγ and IGF-1, Daru 31 (2023) 13–27"
            },
            {
                "key": "ref121",
                "doi": "10.1016/j.nutres.2022.06.010",
                "unstructured": "Q. Zhang, X. Zhou, J. Zhang, et al., Selenium and vitamin B(6) cosupplementation improves dyslipidemia and fatty liver syndrome by SIRT1/ SREBP-1c pathway in hyperlipidemic Sprague-Dawley rats induced by high-fat diet, Nutr. Res 106 (2022) 101–118"
            },
            {
                "key": "ref122",
                "doi": "10.3390/molecules27249033",
                "unstructured": "X. Yu, X. Meng, Y. Yan, et al., Extraction of naringin from pomelo and its therapeutic potentials against hyperlipidemia, Molecules 27 (2022"
            },
            {
                "key": "ref123",
                "doi": "10.2174/1871530321666210809152555",
                "unstructured": "Q. Zhang, D.L. Zhang, X.L. Zhou, et al., Antihyperlipidemic and hepatoprotective properties of vitamin b6 supplementation in rats with highfat diet-induced hyperlipidemia, Endocr. Metab. Immune Disord. Drug Targets 21 (2021) 2260–2272"
            },
            {
                "key": "ref124",
                "doi": "10.1016/j.mce.2023.111881",
                "unstructured": "V.M.M. Andrade, A.F. de Moura, K. da Costa Chaves, et al., Yerba mate consumption by ovariectomized rats alters white adipose tissue, Mol. Cell Endocrinol. 564 (2023), 111881"
            },
            {
                "key": "ref125",
                "doi": "10.3390/nu14030446",
                "unstructured": "Y.Y. Sung, S.H. Kim, D.S. Kim, Combined phyllostachys pubescens and scutellaria baicalensis prevent high-fat diet-induced obesity via upregulating thermogenesis and energy expenditure by UCP1 in Male C57BL/6J Mice, Nutrients 14 (2022) 446"
            },
            {
                "key": "ref126",
                "doi": "10.1016/j.jep.2022.115101",
                "unstructured": "Z. Xie, E.W. Li, G. Gao, et al., Zexie Tang targeting FKBP38/mTOR/SREBPs pathway improves hyperlipidemia, J. Ethnopharmacol. 290 (2022), 115101"
            },
            {
                "key": "ref127",
                "doi": "10.1016/j.lfs.2020.118721",
                "unstructured": "B. Hui, X. Hou, R. Liu, et al., Gypenoside inhibits ox-LDL uptake and foam cell formation through enhancing Sirt1-FOXO1 mediated autophagy flux restoration, Life Sci. 264 (2021), 118721"
            },
            {
                "key": "ref128",
                "doi": "10.3390/ijms23158384",
                "unstructured": "D.Y. Hong, D.H. Lee, J.Y. Lee, et al., Relationship between brain metabolic disorders and cognitive impairment: LDL receptor defect, Int J. Mol. Sci. 23 (2022) 8384"
            },
            {
                "key": "ref129",
                "doi": "10.1002/hep.26088",
                "unstructured": "T.A. Kerr, N.O. Davidson, Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain, Hepatology 56 (2012) 1995–199"
            },
            {
                "key": "ref130",
                "doi": "10.1016/j.bbrc.2009.01.163",
                "unstructured": "G.L. Wang, Y.C. Fu, W.C. Xu, et al., Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway, Biochem Biophys. Res Commun. 380 (2009) 644–649"
            },
            {
                "key": "ref131",
                "doi": "10.3389/fnut.2020.596285",
                "unstructured": "Y. Ye, H. Xu, Z. Xie, et al., Time-restricted feeding reduces the detrimental effects of a high-fat diet, possibly by modulating the circadian rhythm of hepatic lipid metabolism and gut microbiota, Front Nutr. 7 (2020), 596285"
            },
            {
                "key": "ref132",
                "doi": "10.1021/acs.jafc.0c07342.s001",
                "unstructured": "J. Xia, P. Yu, Z. Zeng, et al., Lauric triglyceride ameliorates high-fat-diet-induced obesity in rats by reducing lipogenesis and increasing lipolysis and β-oxidation, J. Agric. Food Chem. 69 (2021) 9157–9166, P. Singh, M.I. Reza, A.A. Syed, et al., PSTi8 with metformin ameliorates perimenopause induced steatohepatitis associated ER stress by regulating SIRT-1/ SREBP-1c axis, Heliyon 6 (2020), e05826"
            },
            {
                "key": "ref133",
                "doi": "10.3389/fimmu.2021.694720",
                "unstructured": "M. Jin, Y. Shen, T. Pan, et al., Dietary betaine mitigates hepatic steatosis and inflammation induced by a high-fat-diet by modulating the Sirt1/ Srebp-1/Ppar， pathway in juvenile black seabream (Acanthopagrus schlegelii), Front Immunol. 12 (2021), 694720"
            },
            {
                "key": "ref134",
                "doi": "10.1002/ptr.7526",
                "unstructured": "T.H. Pham, G.H. Lee, S.W. Jin, et al., Puerarin DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3866 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders attenuates hepatic steatosis via G- protein-coupled estrogen receptor-mediated calcium and SIRT1 signaling pathways, Phytother. Res 36 (2022) 3601–3618"
            },
            {
                "key": "ref135",
                "doi": "10.1039/d2fo01934e",
                "unstructured": "H. Zhao, Y. Tian, Y. Zuo, et al., Nicotinamide riboside ameliorates high-fructose- induced lipid metabolism disorder in mice via improving FGF21 resistance in the liver and white adipose tissue, Food Funct. 13 (2022) 12400–12411"
            },
            {
                "key": "ref136",
                "doi": "10.1038/s41598-017-18529-x",
                "unstructured": "R. Singaravelu, C. Quan, M.H. Powdrill, et al., MicroRNA-7 mediates cross-talk between metabolic signaling pathways in the liver, Sci. Rep. 8 (2018) 361"
            },
            {
                "key": "ref137",
                "doi": "10.1016/j.biopha.2020.109836",
                "unstructured": "C. Yuan, Y. Jin, L. Yao, et al., Rhodiola crenulata root extract ameliorates fructose-induced hepatic steatosis in rats: Association with activating autophagy, Biomed. Pharm. 125 (2020), 109836"
            },
            {
                "key": "ref138",
                "doi": "10.1021/acs.jafc.9b05632.s002",
                "unstructured": "D. Ilbeigi, M. Nourbakhsh, P. Pasalar, et al., Nicotinamide Phosphoribosyltransferase Knockdown Leads to Lipid Accumulation in HepG2 Cells through The SIRT1-AMPK Pathway, Cell J. 22 (2020) 125–132"
            },
            {
                "key": "ref139",
                "doi": "10.1016/j.phymed.2023.155005",
                "unstructured": "X. Yin, Z. Liu, J. Wang, Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP- 1c-Sirt1 signaling axis, Phytomedicine 119 (2023), 155005"
            },
            {
                "key": "ref140",
                "doi": "10.2147/dddt.s256504",
                "unstructured": "G. Wang, B. Wu, W. Xu, et al., The inhibitory effects of juglanin on adipogenesis in 3T3-L1 adipocytes, Drug Des. Devel Ther. 14 (2020) 5349–5357"
            },
            {
                "key": "ref141",
                "doi": "10.1016/j.scitotenv.2021.147182",
                "unstructured": "alcoholic fatty liver disease in rats by stimulating miR-34a/SIRT1/FXR/p53 axis, Sci. Total Environ. 784 (2021), 14718"
            },
            {
                "key": "ref142",
                "doi": "10.1080/13813455.2022.2046106",
                "unstructured": "M.N. BinMowyna, N.A. AlFaris, E.A. Al-Sanea, et al., Resveratrol attenuates against high-fat-dietpromoted non-alcoholic fatty liver disease in rats mainly by targeting the miR-34a/SIRT1 axis, Arch. Physiol. Biochem (2022) 1–16"
            },
            {
                "key": "ref143",
                "doi": "10.1016/j.jep.2022.115237",
                "unstructured": "M.S. Poornima, G. Sindhu, A. Billu, et al., Pretreatment of hydroethanolic extract of Dillenia indica L. attenuates oleic acid induced NAFLD in HepG2 cells via modulating SIRT-1/p-LKB-1/ AMPK, HMGCR & PPAR-α signaling pathways. J Ethnopharmacol 292 (2022), 115237"
            },
            {
                "key": "ref144",
                "doi": "10.1021/acs.jafc.9b04259",
                "unstructured": "W.Y. Wu, X.Q. Ding, T.T. Gu, et al., Pterostilbene improves hepatic lipid accumulation via the MiR- 34a/Sirt1/SREBP-1 pathway in fructose-fed rats, J. Agric. Food Chem. 68 (2020) 1436–1446"
            },
            {
                "key": "ref145",
                "doi": "10.1111/hepr.12089",
                "unstructured": "L.J. Sun, S.C. Li, Y.H. Zhao, et al., Silent information regulator 1 inhibition induces lipid metabolism disorders of hepatocytes and enhances hepatitis C virus replication, Hepatol. Res 43 (2013) 1343–1351"
            },
            {
                "key": "ref146",
                "doi": "10.1111/hepr.12089",
                "unstructured": "L.J. Sun, Y.H. Zhao, S.C. Li, et al., [Inhibition of silent information regulator-1 in hepatocytes induces lipid metabolism disorders and enhances hepatitis C virus replication], Zhonghua Gan Zang Bing. Za Zhi 21 (2013) 834–839"
            },
            {
                "key": "ref147",
                "doi": "10.1021/acs.jafc.9b02045",
                "unstructured": "S. Liu, Q. Sui, Y. Zhao, et al., Lonicera caerulea Berry Polyphenols Activate SIRT1, Enhancing Inhibition of Raw264.7 Macrophage Foam Cell Formation and Promoting Cholesterol Efflux, J. Agric. Food Chem. 67 (2019) 7157–7166"
            },
            {
                "key": "ref148",
                "doi": "10.1007/s11033-021-07109-y",
                "unstructured": "M. Mahmudpour, K. Vahdat, M. Keshavarz, et al., The COVID-19-diabetes mellitus molecular tetrahedron, Mol. Biol. Rep. 49 (2022) 4013–4024"
            },
            {
                "key": "ref149",
                "doi": "10.1016/j.fct.2023.113781",
                "unstructured": "M. Kim, S.H. Kim, J.Y. Choi, et al., Investigating fatty liver disease-associated adverse outcome pathways of perfluorooctane sulfonate using a systemstoxicology approach, Food Chem. Toxicol. 176 (2023), 113781S. Liu, X. Chang, J. Yu, et al., Cerasus humilis cherry polyphenol reduces high-fat diet-induced obesity in C57BL/6 mice by mitigating fat deposition, inflammation, and oxidation, J. Agric. Food Chem. 68 (2020) 4424–4436"
            },
            {
                "key": "ref150",
                "doi": "10.1016/j.biocel.2021.105932",
                "unstructured": "N. Wang, D. Wang, G. Luo, et al., Lutein attenuates excessive lipid accumulation in differentiated 3T3-L1 cells and abdominal adipose tissue of rats by the SIRT1- mediated pathway, Int J. Biochem Cell Biol. 133 (2021), 105932"
            },
            {
                "key": "ref151",
                "doi": "10.3390/cimb43030128",
                "unstructured": "H.M. Liu, C.H. Wang, Z.Y. Chang, et al., Losartan attenuates insulin resistance and regulates browning phenomenon of white adipose tissue in ob/ob mice, Curr. Issues Mol. Biol. 43 (2021) 1828–1843"
            },
            {
                "key": "ref152",
                "doi": "10.1016/j.celrep.2023.112155",
                "unstructured": "T.R. Madaris, M. Venkatesan, S. Maity, et al., Limiting Mrs2-dependent mitochondrial Mg(2+) uptake induces metabolic programming in prolonged dietary stress, Cell Rep. 42 (2023), 112155"
            },
            {
                "key": "ref153",
                "doi": "10.1371/journal.pone.0043490",
                "unstructured": "A. Defour, K. Dessalle, A. Castro Perez, et al., Sirtuin 1 regulates SREBP-1c expression in a LXRdependent manner in skeletal muscle, PLoS One 7 (2012), e43490"
            },
            {
                "key": "ref154",
                "doi": "10.1016/j.freeradbiomed.2015.12.022",
                "unstructured": "R. Mastrocola, D. Nigro, F. Chiazza, et al., Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice, Free Radic. Biol. Med 91 (2016) 224–235, DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3867 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders"
            },
            {
                "key": "ref155",
                "doi": "10.1186/s12863-020-0836-7",
                "unstructured": "W. Wang, X. Li, N. Ding, et al., miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4, BMC Genet 21 (2020), 33"
            },
            {
                "key": "ref156",
                "doi": "10.3390/nu14081680",
                "unstructured": "H.Y. Lee, G.H. Lee, T.H. Hoang, et al., GABA and Fermented Curcuma longa L. Extract Enriched with GABA Ameliorate Obesity through Nox4-IRE1α Sulfonation-RIDD-SIRT1 Decay Axis in High-Fat Diet-Induced Obese Mice, Nutrients 14 (2022) 1680"
            },
            {
                "key": "ref157",
                "doi": "10.1016/j.neuroscience.2021.09.017",
                "unstructured": "M.A. Paulazo, A.O. Sodero, SIRT-1 activity sustains cholesterol synthesis in the brain, Neuroscience 476 (2021) 116–124"
            },
            {
                "key": "ref158",
                "doi": "10.1186/s13046-021-02223-y",
                "unstructured": "D.V. Pham, P.H. Park, Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming, J. Exp. Clin. Cancer Res 41 (2022), 9"
            },
            {
                "key": "ref159",
                "doi": "10.1161/circulationaha.114.013675",
                "unstructured": "Z. Chen, L. Wen, M. Martin, et al., Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a, Circulation 131 (2015) 805–814"
            },
            {
                "key": "ref160",
                "doi": "10.3892/mmr.2015.4286",
                "unstructured": "Y. Zhang, H. Li, Y. Cao, et al., Sirtuin 1 regulates lipid metabolism associated with optic nerve regeneration, Mol. Med Rep. 12 (2015) 6962–6968"
            },
            {
                "key": "ref161",
                "doi": "10.1016/j.biopha.2022.112908",
                "unstructured": "S.G. Mladenova, M.S. Savova, A.S. Marchev, et al., Anti-adipogenic activity of maackiain and ononin is mediated via inhibition of PPARγ in human adipocytes, Biomed. Pharm. 149 (2022), 112908"
            },
            {
                "key": "ref162",
                "doi": "10.1016/j.jnutbio.2022.108948",
                "unstructured": "A.D. Kp, A.R. Shimoga Janakirama, A. Martin, SIRT1 activation by Taurine: in vitro evaluation, molecular docking and molecular dynamics simulation studies, J. Nutr. Biochem 102 (2022), 108948 A. Dare, M.L. Channa, A. Nadar, L-ergothioneine and metformin alleviates liver injury in experimental type-2 diabetic rats via reduction of oxidative stress, inflammation, and hypertriglyceridemia, Can. J. Physiol. Pharm. 99 (2021) 1137–1147"
            },
            {
                "key": "ref163",
                "doi": "10.1016/j.ejphar.2021.173976",
                "unstructured": "H. Zhou, C. Ma, C. Wang, et al., Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease, Eur. J. Pharm. 898 (2021), 173976"
            },
            {
                "key": "ref164",
                "doi": "10.1155/2023/2970429",
                "unstructured": "Y. Jiang, Y. Wang, S. Chen, et al., Screening of biomarkers in liver tissue after bariatric surgery based on WGCNA and SVM-RFE Algorithms, Dis. Markers 2023 (2023) 2970429"
            },
            {
                "key": "ref165",
                "doi": "10.3390/biom12081079",
                "unstructured": "C. Zeng, M. Chen, Progress in nonalcoholic fatty liver disease: SIRT family regulates mitochondrial biogenesis, Biomolecules 12 (2022) 1079"
            },
            {
                "key": "ref166",
                "doi": "10.1002/ptr.7101",
                "unstructured": "L. Zhang, S.Y. Yang, F.R. Qi-Li, et al., Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2-CREB-SIRT1 axis, Phytother. Res 35 (2021) 3898–3915"
            },
            {
                "key": "ref167",
                "doi": "10.1002/path.5548",
                "unstructured": "J. Ryu, E. Kim, M.K. Kang, et al., Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression, J. Pathol. 253 (2021) 55–67"
            },
            {
                "key": "ref168",
                "doi": "10.1111/jcmm.13297",
                "unstructured": "L.F. Wang, L.J. Miao, X.N. Wang, et al., CD38 deficiency suppresses adipogenesis and lipogenesis in adipose tissues through activating Sirt1/PPARγ signaling pathway, J. Cell Mol. Med 22 (2018) 101–110"
            },
            {
                "key": "ref169",
                "doi": "10.1016/j.ejmech.2017.11.017",
                "unstructured": "C. Li, B. Cheng, S. Fang, et al., Design, syntheses and lipid accumulation inhibitory activities of novel resveratrol mimics, Eur. J. Med Chem. 143 (2018) 114–122"
            },
            {
                "key": "ref170",
                "doi": "10.1002/jsfa.9617",
                "unstructured": "M. Aghasi, F. Koohdani, M. Qorbani, et al., Beneficial effects of green cardamom on serum SIRT1, glycemic indices and triglyceride levels in patients with type 2 diabetes mellitus: a randomized double-blind placebo controlled clinical trial, J. Sci. Food Agric. 99 (2019) 3933–3940"
            },
            {
                "key": "ref171",
                "doi": "10.1111/acel.12220",
                "unstructured": "E.M. Mercken, S.J. Mitchell, A. Martin-Montalvo, et al., SRT2104 extends survival of male mice on a standard diet and preserves bone and muscle mass, Aging Cell 13 (2014) 787–796, R.K. Minor, J.A. Baur, A.P. Gomes, et al., SRT1720 improves survival and healthspan of obese mice, Sci. Rep. 1 (2011), 70"
            },
            {
                "key": "ref172",
                "doi": "10.1038/nature06261",
                "unstructured": "J.C. Milne, P.D. Lambert, S. Schenk, et al., Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes, Nature 450 (2007) 712–716"
            },
            {
                "key": "ref173",
                "doi": "10.1002/pro.50",
                "unstructured": "L. Jin, H. Galonek, K. Israelian, et al., Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3, Protein Sci. 18 (2009) 514–525"
            },
            {
                "key": "ref174",
                "doi": "10.1107/s0907444913015448",
                "unstructured": "G.T. Nguyen, S. Schaefer, M. Gertz, et al., Structures of human sirtuin 3 complexes with ADPribose and with carba-NAD+ and SRT1720: binding details and inhibition mechanism, Acta Crystallogr D. Biol. Crystallogr 69 (2013) 1423–1432"
            },
            {
                "key": "ref175",
                "doi": "10.1096/fj.202200169r",
                "unstructured": "C.A. Smith, P.A. Humphreys, N. Bates, et al., SIRT1 activity orchestrates ECM expression during hESC-chondrogenic differentiation, Faseb J. 36 (2022), e22314,. DOI:https://doi.org/10.46243/jst.2024.v9.i02.pp01-3868 B Sandhya Rani, I. Triveni, B.Revathi, N. Danamurthy: Therapeutic Targeting of the SIRT1-SREBP Pathway in Metabolic Disorders"
            },
            {
                "key": "ref176",
                "doi": "10.1016/j.pharmthera.2018.03.004",
                "unstructured": "H. Dai, D.A. Sinclair, J.L. Ellis, et al., Sirtuin activators and inhibitors: promises, achievements, and challenges, Pharm. Ther. 188 (2018) 140–154"
            },
            {
                "key": "ref177",
                "doi": "10.1136/openhrt-2016-000402",
                "unstructured": "S. Venkatasubramanian, R.M. Noh, S. Daga, et al., Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus, Open Heart 3 (2016), e000402"
            },
            {
                "key": "ref178",
                "doi": "10.1123/ijsnem.2013-0045",
                "unstructured": "K.P. Goh, H.Y. Lee, D.P. Lau, et al., Effects of resveratrol in patients with type 2 diabetes mellitus on skeletal muscle SIRT1 expression and energy expenditure, Int J. Sport Nutr. Exerc Metab. 24 (2014) 2–13S. Timmers, E. Konings, L. Bilet, et al., Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans, Cell Metab. 14 (2011) 612–622"
            },
            {
                "key": "ref179",
                "doi": "10.1002/jimd.12479",
                "unstructured": "J.H. Storgaard, N. Løkken, K.L. Madsen, et al., No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: a randomized clinical cross-over trial, J. Inherit. Metab. Dis. 45 (2022) 517–528"
            },
            {
                "key": "ref180",
                "doi": "10.1016/j.ijcard.2016.10.058",
                "unstructured": "A.P. Mansur, A. Roggerio, M.F.S. Goes, et al., Serum concentrations and gene expression of sirtuin 1 in healthy and slightly overweight subjects after caloric restriction or resveratrol supplementation: a randomized trial, Int J. Cardiol. 227 (2017) 788–794"
            },
            {
                "key": "ref181",
                "doi": "10.1371/journal.pone.0051395",
                "unstructured": "V. Libri, A.P. Brown, G. Gambarota, et al., A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers, PLoS One 7 (2012), e51395"
            },
            {
                "key": "ref182",
                "doi": "10.2337/dc06-1962",
                "unstructured": "I. Bogacka, T.W. Gettys, L. de Jonge, et al., The effect of beta-adrenergic and peroxisome proliferator-activated receptor-gamma stimulation on target genes related to lipid metabolism in human subcutaneous adipose tissue, Diabetes Care 30 (2007) 1179–1186"
            },
            {
                "key": "ref183",
                "doi": "10.1111/apt.14674",
                "unstructured": "N. Chalasani, R. Vuppalanchi, M. Rinella, et al., Randomised clinical trial: a leucine-metforminsildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease, Aliment Pharm. Ther. 47 (2018) 1639–1651"
            }
        ],
        "record": {
            "registrant": "Longman Publishers",
            "registered": "2026-08-26",
            "updated": "2026-09-20",
            "issue_number": 1,
            "source": "crossref-api",
            "source_agency": "Crossref (member 25296)"
        }
    },
    "record_sha256": "1042706a6655dc1f8bb091b3044d8e8bd4127f2f3cf7af183be2c3562ee8eeb4",
    "handle": {
        "synced_at": "2026-10-01 18:12:56",
        "url": "https://jst.org.in/index.php/pub/article/view/1460"
    },
    "links": {
        "record_page": "https://registry.smartscholars.in/record.php?doi=10.46243%2Fjst.2024.v9.i2.pp72-110",
        "system_metadata": "https://registry.smartscholars.in/resolve.php?doi=10.46243%2Fjst.2024.v9.i2.pp72-110&as=system",
        "history": "https://registry.smartscholars.in/api.php?action=history&doi=10.46243%2Fjst.2024.v9.i2.pp72-110",
        "kernel_xml": "https://registry.smartscholars.in/resolve.php?doi=10.46243%2Fjst.2024.v9.i2.pp72-110&as=xml"
    }
}